North America Smart Inhalers Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
to 2027 - Regional Analysis and Forecasts by Product (Nebulizers and Inhalers); Disorder (Chronic Obstructive Pulmonary Disease (COPD), and Asthma); End User (Home-Care Settings and Hospitals & Clinics), and Country

No. of Pages: 110    |    Report Code: TIPRE00006805    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Smart Inhalers Market

1.              Introduction

1.1       Scope Of The Study

1.2       The Insight Partners Research Report Guidance

2.              North America Smart Inhalers Market Market – Key Takeaways

3.              North America Smart Inhalers Market – Market Landscape

3.1       Overview

3.2       Market Segmentation

3.2.1       North America Smart Inhalers Market – By Product

3.2.2       North America Smart Inhalers Market – By Disorder

3.2.3       North America Smart Inhalers Market – By End User

3.2.4       North America Smart Inhalers Market – By North America Region

3.3       Pest Analysis

4.              North Americasmart Inhalers Market – Key Market Dynamics

4.1       Key Market Drivers

4.1.1       Increasing Levels of Air Pollution as well as Rise in the Smoking Habits

4.1.2       Rising Prevalence of Asthma and COPD Across the North America

4.1.3       Growing Geriatric Population

4.2       Key Market Restraints

4.2.1       Risks Associated with Cyber Threats

4.2.2       Limited Knowledge Regarding the Use of Smart Inhalers

4.3       Key Market Opportunity

4.3.1       Growth in the North America Healthcare Market

4.4       Future Trend

4.4.1       Increasing Acceptance of Mobile Health Technology

4.5       Impact Analysis

5.              Smart Inhalers Market – North America Analysis

5.1       North America Smart Inhalers Market Revenue Forecasts And Analysis

5.2       Performance Of Key Players

6.              Smart Inhalers Market Analysis And Forecasts To 2027 – Product

6.1       Overview

6.2       North America Smart Inhalers Market Share By PRODUCT 2018 & 2027 (%)

6.3       Inhalers Market

6.3.1       Overview

6.3.2       Inhalers Market Revenue and Forecast to 2027 (US$ Mn)

6.4       Nebulizers Market

6.4.1       Overview

6.4.2       Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)

7.              Smart Inhalers Market Analysis And Forecasts To 2027 – Disorder

7.1       Overview

7.2       North America Smart Inhalers Market Share By Application 2018 & 2027 (%)

7.3       Asthma Diabetes

7.3.1       Overview

7.3.2       Asthma Market Revenue and Forecast to 2027 (US$ Mn)

7.4       CHRONIC OBSTRUCTIVE PULMONARY DISEASE Market

7.4.1       Overview

7.4.2       Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2027 (US$ Mn)

8.              Smart Inhalers Market Analysis And Forecasts To 2027 – End User

8.1       Overview

8.2       North America Smart Inhalers Market Share By End User 2018 & 2027 (%)

8.3       Hospitals & Clinics Market

8.3.1       Overview

8.3.2       Hospitals & Clinics Market Revenue and Forecast to 2027 (US$ Mn)

8.4       Home Care Settings Market

8.4.1       Overview

8.4.2       Home-Care Settings Market Revenue and Forecast to 2027 (US$ Mn)

9.              Smart Inhalers Market Revenue And Forecasts To 2027 – North America Analysis

9.1       North America Smart Inhalers Market Revenue And Forecasts To 2027

9.1.1       North America Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.2       North America Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.3       North America Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.4       North America Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.5       North America Smart Inhalers Market Revenue And Forecasts to 2027, By Country (%)

9.1.6       US Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.1    US Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.2    US Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.6.3    US Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.6.4    US Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.7       Canada Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1    Canada Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.2    Canada Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.7.3    Canada Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.7.4    Canada Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.8       Mexico Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.1    Mexico Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.2    Mexico Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.8.3    Mexico Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.8.4    Mexico Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.           Smart Inhalers Market– Industry Landscape

10.1    Overview

10.2    Comparative Company Analysis

10.3    Growth Strategies Done By The Companies In The Market, (%)

10.4    Organic Developments

10.4.1    Overview

10.5    Inorganic Developments

10.5.1    Overview

11.           Smart Inhalers Market–Key Company Profiles

11.1    Glaxosmithkline Plc.

11.1.1    Key Facts

11.1.2    Business Description

11.1.3    Financial Overview

11.1.4    Product Portfolio

11.1.5    SWOT Analysis

11.1.6    Key Developments

11.2    Adherium Limited

11.2.1    Key Facts

11.2.2    Business Description

11.2.3    Financial Overview

11.2.4    Product Portfolio

11.2.5    SWOT Analysis

11.2.6    Key Developments

11.3    Novartis AG

11.3.1    Key Facts

11.3.2    Business Description

11.3.3    Financial Overview

11.3.4    Product Portfolio

11.3.5    SWOT Analysis

11.3.6    Key Developments

11.4    Vectura Group Plc

11.4.1    Key Facts

11.4.2    Business Description

11.4.3    Financial Overview

11.4.1    Product Portfolio

11.4.2    SWOT Analysis

11.4.3    Key Developments

11.5    Cohero Health, Inc.

11.5.1    Key Facts

11.5.2    Business Description

11.5.3    Financial Overview

11.5.4    Product Portfolio

11.5.5    SWOT Analysis

11.5.6    Key Developments

11.6    Crux Product Design Ltd

11.6.1    Key Facts

11.6.2    Business Description

11.6.3    Financial Information

11.6.4    Product Portfolio

11.6.5    SWOT Analysis

11.6.6    Key Developments

11.7    Findair Sp. Z O. O.

11.7.1    Key Facts

11.7.2    Business Description

11.7.3    Financial Overview

11.7.4    Product Portfolio

11.7.5    SWOT Analysis

11.7.6    Key Developments

11.8    Teva Pharmaceutical Industries Ltd.

11.8.1    Key Facts

11.8.2    Business Description

11.8.3    Financial Overview

11.8.4    Product Portfolio

11.8.5    SWOT Analysis

11.8.6    Key Developments

11.9    3m

11.9.1    Key Facts

11.9.2    Business Description

11.9.3    Financial Overview

11.9.4    Product Portfolio

11.9.5    SWOT Analysis

11.9.6    Key Developments

11.10  Amiko Digital Health Limited

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial Overview

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

12.           Appendix

12.1    About The Insight Partners

12.2    Glossary Of Terms

 

LIST OF TABLES

Table 1.            Total Number Of Persons Aged 60 Years Or Above In North America, 2017 & 2050

Table 2.            North America Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 3.            North America Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)

Table 4.            North America Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 5.            US Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 6.            US Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)

Table 7.            US Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 8.            Canada Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 9.            Canada Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)

Table 10.         Canada Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 11.         Mexico Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 12.         Mexico Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)

Table 13.         Mexico Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 14.         Organic Developments Done By Companies

Table 15.         Inorganic Developments Done By Companies

Table 16.         Glossary Of Terms, Smart Inhalers Market

 

LIST OF FIGURES

Figure 1.          US Smart Inhalers Market, Revenue (US$ Mn), 2018 & 2027

Figure 2.          North America Smart Inhalers Market By Product, Market Share (%), 2018

Figure 3.          North America Smart Inhalers Market By Disorder, Market Share (%), 2018

Figure 4.          North America Smart Inhalerss Market By End User, Market Share (%), 2018

Figure 5.          Smart Inhalers Market Segmentation

Figure 6.          Smart Inhalers Market Segmentation, By Region

Figure 7.          North America Pest Analysis

Figure 8.          North America Smart Inhalers Market Impact Analysis Of Driver And Restraints

Figure 9.          North America Smart Inhalers Market – Revenue Forecasts And Analysis –2018- 2027

Figure 10.       Market Positioning Of Key Player In North America Smart Inhalers Market

Figure 11.       North America Smart Inhalers Market Share By Product 2018 & 2027 (%)

Figure 12.       Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 13.       Nebulizers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14.       North America Smart Inhalers Market Share By Application 2018 & 2027 (%)

Figure 15.       Asthma Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.       Chronic Obstructive Pulmonary Disease Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 17.       North America Smart Inhalers Market Share By End User 2018 & 2027 (%)

Figure 18.       Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       Home-Care Settings Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.       North America Smart Inhalers Market REVENUE Overview, By Country, 2018 (US$ MN)

Figure 21.       North America Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22.       North America Smart Inhalers Market Revenue And Forecasts To 2027, By Country (%)

Figure 23.       US Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.       Canada Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 25.       Mexico Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26.       Comparative Company Analysis

Figure 27.       Growth Strategies Done By The Companies In The Market, (%)

The List of Companies - North America Smart Inhalers Market

The List of Companies

  1. GlaxoSmithKline plc
  2. Adherium Ltd.
  3. Vectura Group plc
  4. Novartis AG
  5. Findair Sp. z o. o.
  6. Cohero Health
  7. Crux Product Design Ltd
  8. Teva Pharmaceuticals
  9. 3M
  10. Amiko Digital Health Limited